Medline Inc. announces pricing of secondary offering of Class A common stock
Key Highlights
- ➤60 million Class A shares priced at $35.50 each in secondary offering
- ➤Selling stockholders granted underwriters a 30-day option for 9 million additional shares
- ➤Medline receives no proceeds because selling stockholders are offering all shares
- ➤Medline and Medline Holdings agreed to repurchase $200 million in equity interests
- ➤Offering and repurchase are expected to close November 23, 2026, subject to conditions
NORTHFIELD, Ill., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its secondary offering of 60,000,000 shares of Medline’s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC along with GIC Private Limited and its managed affiliate and a wholly owned subsidiary of the Abu Dhabi Investment Authority (collectively, the “Selling Stockholders”) at a price to the public of $35.50 per share (the “Offering”). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline’s Class A common stock. The Offering is expected to close on November 23, 2026, subject to customary closing conditions.
Medline is not selling any shares of Class A common stock in the Offering and will not receive any of the proceeds from the sale.
Get started
Create a free account to read the full story.
